유전자 합성 시장 : 제품, 방법, 유전자 유형, 용도, 최종 용도별 - 세계 예측(2025-2030년)

The Gene Synthesis Market was valued at USD 4.24 billion in 2023, expected to reach USD 4.68 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 8.70 billion by 2030.

Gene synthesis refers to the enzymatic or chemical assembly of gene sequences from scratch. It plays a pivotal role in synthetic biology, enabling researchers to create specific DNA sequences for various purposes. Its necessity arises from its ability to expedite the process of obtaining synthetic genes with desired biological properties, which is significantly faster than traditional cloning methods. Applications of gene synthesis span multiple domains, including pharmaceuticals, agriculture, vaccine development, and industrial biotechnology, with end-use industries leveraging it for product development, research, and therapeutic efficacy.

Market insights indicate a robust growth trajectory for gene synthesis driven by increasing demand for personalized medicine, advancements in genetic engineering, and heightened R&D activities. The rise in synthetic biology applications, alongside decreasing costs of gene synthesis, further fuels this growth. However, challenges persist, such as ethical controversies, regulatory complexities, and potential misuse of synthetic genes. A major limitation is the technical complexity involved in assembling long or highly complex genes, which can affect costs and lead time.

Opportunities in the market are vast, particularly in the development of new therapeutic drugs and vaccines, crafting drought-resistant crops, and enhancing biofuel production. Companies can capitalize on these by investing in technologies that improve synthesis accuracy and reduce error rates. Additionally, partnerships with research institutions could expedite innovations in applications like CRISPR gene-editing systems.

Key areas for innovation include developing more sophisticated algorithms for sequence design, improving base-pair synthesis accuracy, and enhancing the scalability of synthesis processes to handle larger genetic sequences. Business growth can be further accelerated by addressing the unmet needs in customizable gene synthesis and expanding service offerings to non-traditional biotech markets. Hence, for sustained competitive advantage, companies should focus on improving process efficiencies and expanding application potential, all while navigating the regulatory landscape to address societal and ethical concerns associated with gene synthesis.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Synthesis Market

The Gene Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic conditions among the global population
  • Increasing genomics research activities and rising focus on personalized medicines
  • Growing investments by the private and public sectors in pharmaceutical research
• Market Restraints
  • Strict regulations governing gene synthesis and high cost associated with the process
• Market Opportunities
  • Emerging new technologies in gene synthesis
  • Utilization of gene synthesis in energy and agriculture industries
• Market Challenges
  • Limitations in size and complexity of synthetic genes

Porter's Five Forces: A Strategic Tool for Navigating the Gene Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Synthesis Market

A detailed market share analysis in the Gene Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Biomatik Corporation, Biotech Desk Pvt. Ltd., Twist Bioscience Corporation, ProteoGenix SAS, Creative Biogene, Biotage AB, General Biosystems, Inc., Ansa Biotechnologies, Inc., ProMab Biotechnologies, Inc., Barcode Biosciences Private Limited, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Eurofins Scientific SE, Telesis Bio Inc., Macrogen, Inc., Elegen Corp., Gene Universal, Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Synbio Technologies LLC, Danaher Corporation, Constructive Bio Ltd, GenCefe Biotech Limited, NZYTech, Lda., Evonetix Ltd., OriGene Technologies, Inc., BGI Genomics by BGI Group, Boster Biological Technology, Bioneer Corporation, Brooks Automation Inc., QIAGEN N.V., Agilent Technologies, Inc., Merck KGaA, AstraZeneca PLC, Ginkgo Bioworks Holdings, Inc., GenScript Biotech Corporation, Camena Bioscience, Azenta, Inc., BioCat GmbH by AddLife AB, and Applied Biological Materials Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Hardware, Services, and Software. The Services is further studied across Antibody DNA Synthesis and Viral DNA Synthesis.
• Based on Method, market is studied across Chip-Based Synthesis, PCR-Based Enzyme Synthesis, and Solid-Phase Synthesis.
• Based on Gene Type, market is studied across Complex Gene, Express Gene, and Standard Gene.
• Based on Application, market is studied across Disease Diagnosis, Gene & Cell Therapy Development, and Vaccine Development.
• Based on End-use, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic conditions among the global population
    • 5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
    • 5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
  • 5.1.2. Restraints
    • 5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging new technologies in gene synthesis
    • 5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations in size and complexity of synthetic genes
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
  • 5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
  • 5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
  • 5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
  • 5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Synthesis Market, by Product

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Services
  • 6.3.1. Antibody DNA Synthesis
  • 6.3.2. Viral DNA Synthesis
• 6.4. Software

7. Gene Synthesis Market, by Method

• 7.1. Introduction
• 7.2. Chip-Based Synthesis
• 7.3. PCR-Based Enzyme Synthesis
• 7.4. Solid-Phase Synthesis

8. Gene Synthesis Market, by Gene Type

• 8.1. Introduction
• 8.2. Complex Gene
• 8.3. Express Gene
• 8.4. Standard Gene

9. Gene Synthesis Market, by Application

• 9.1. Introduction
• 9.2. Disease Diagnosis
• 9.3. Gene & Cell Therapy Development
• 9.4. Vaccine Development

10. Gene Synthesis Market, by End-use

• 10.1. Introduction
• 10.2. Academic & Government Research Institutes
• 10.3. Biotechnology & Pharmaceutical Companies
• 10.4. Contract Research Organizations

11. Americas Gene Synthesis Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Gene Synthesis Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Gene Synthesis Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
  • 14.3.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
  • 14.3.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
  • 14.3.4. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
  • 14.3.5. Biotech Firm Closes GBP 5.6 million Seed Financing
  • 14.3.6. Bruker to Buy PhenomeX For USD 108 Million
  • 14.3.7. Series Funding to Support Expansion of DNA Synthesis Technology
  • 14.3.8. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
  • 14.3.9. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
  • 14.3.10. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
  • 14.3.11. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
  • 14.3.12. Evonetix Closes USD 24 million Financing
  • 14.3.13. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
  • 14.3.14. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression

Companies Mentioned

• 1. Biomatik Corporation
• 2. Biotech Desk Pvt. Ltd.
• 3. Twist Bioscience Corporation
• 4. ProteoGenix SAS
• 5. Creative Biogene
• 6. Biotage AB
• 7. General Biosystems, Inc.
• 8. Ansa Biotechnologies, Inc.
• 9. ProMab Biotechnologies, Inc.
• 10. Barcode Biosciences Private Limited
• 11. DNA TwoPointO Inc.
• 12. Elabscience Biotechnology Inc.
• 13. Eurofins Scientific SE
• 14. Telesis Bio Inc.
• 15. Macrogen, Inc.
• 16. Elegen Corp.
• 17. Gene Universal, Inc.
• 18. Charles River Laboratories International, Inc.
• 19. Thermo Fisher Scientific Inc.
• 20. Synbio Technologies LLC
• 21. Danaher Corporation
• 22. Constructive Bio Ltd
• 23. GenCefe Biotech Limited
• 24. NZYTech, Lda.
• 25. Evonetix Ltd.
• 26. OriGene Technologies, Inc.
• 27. BGI Genomics by BGI Group
• 28. Boster Biological Technology
• 29. Bioneer Corporation
• 30. Brooks Automation Inc.
• 31. QIAGEN N.V.
• 32. Agilent Technologies, Inc.
• 33. Merck KGaA
• 34. AstraZeneca PLC
• 35. Ginkgo Bioworks Holdings, Inc.
• 36. GenScript Biotech Corporation
• 37. Camena Bioscience
• 38. Azenta, Inc.
• 39. BioCat GmbH by AddLife AB
• 40. Applied Biological Materials Inc.